aclarubicin

This page covers all aclarubicin drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 5-hydroxytryptamine receptor 2B.

Targets

5-hydroxytryptamine receptor 2B

Phase 3 pipeline (1)

• Aclacur · Oncology
  Aclacur works by binding to the 5-hydroxytryptamine receptor 2B, which is involved in cell growth and proliferation.